10-
Heitman, J, N R Movva, et M N Hall. 1991. Targets for cell cycle arrest by
the immunosuppressant rapamycin in yeast.
Science (New York, N.Y.)
253, n°.
5022 (Août 23): 905-909.
11-
Bosotti, R, A Isacchi, et E L Sonnhammer. 2000. FAT: a
novel domain in PIK-related kinases.
Trends in Biochemical Sciences
25, n°. 5
(Mai): 225-227.
12-
Guertin, David A., et David M. Sabatini. 2007. Defining the Role of mTOR
in Cancer.
Cancer Cell
12, n°. 1 (Juillet 10): 9-22.
13-
G. Perez-Tenorio, L. Alkhori, B. Olsson,
et al.
PIK3CA mutations and PTEN
loss correlate with similar prognostic factors and are not mutually exclusive in breast
cancer.
Clin Cancer Res, 13 (2007), pp. 3577–3584.
14-
K. Stemke-Hale, A.M. Gonzalez-Angulo, A. Lluch,
et al.
An integrative
genomic and proteomic analysis of PIK3CA, PTEN, and AKT mutations in breast
cancer.
Cancer Res, 68 (2008), pp. 6084–6091.
15-
M.J. Ellis, L. Lin, R. Crowder,
et al.
Phosphatidyl-inositol-3-kinase alpha
catalytic subunit mutation and response to neoadjuvant endocrine therapy for
estrogen receptor positive breast cancer.
Breast Cancer Res Treat, 119 (2010), pp.
379–39.
16-
I.G. Campbell, S.E. Russell, D.Y. Choong,
et al.
Mutation of the PIK3CA gene
in ovarian and breast cancer.
Cancer Res, 64 (2004), pp. 7678–7681.
17-
A.M. Gonzalez-Angulo, J. Ferrer-Lozano, K. Stemke-Hale,
et al.
PI3K pathway
mutations and PTEN levels in primary and metastatic breast cancer.
Mol Cancer
Ther, 10 (2011), pp. 1093–1101
.
18-
P. Fu, M. Ibusuki, Y. Yamamoto,
et al.
Insulin-like growth factor-1 receptor
gene expression is associated with survival in breast cancer: a comprehensive
analysis of gene copy number, mRNA and protein expression.
Breast Cancer Res
16
